NOTCH1 and cancer: found that enhanced NOTCH signaling promotes uncontrolled cell growth and resistance to cell death in cancer, and that NOTCH1-dependent activation is mediated by inhibiting the cyclin-dependent kinase inhibitor p27 (50).